Novavax (NVAX) Payables (2010 - 2026)
Novavax (NVAX) posted Payables of $22.94 million for Q2 2026, down 54.7% from $50.6 million a year earlier but up 42.5% from the prior quarter.
Analysis
Novavax (NVAX) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Novavax's Payables came in at $24.58 million, down 40.9% from FY2024.
- Annual Payables has declined for three consecutive years, with a five-year compound annual growth rate of -14.7% (FY2020 to FY2025).
- In prior years, Novavax's Payables was $41.58 million in FY2024 (-68.6%), $132.61 million in FY2023 (-75.5%), $541.4 million in FY2022 (+326.1%) and $127.05 million in FY2021 (+133.8%).
- Quarterly Payables has run from a low of $15.23 million in Q3 2025 to a high of $710.66 million in Q2 2022 over five years.
- On a year-over-year basis, Payables has declined in each of the last 14 quarters, with an average decline of 51.5% over the last eight quarters.
- The strongest year-over-year quarter for Payables in the past five years was Q2 2022, with growth of 860.4%; the weakest was Q2 2023, with a decline of 87.7%.
- According to Business Quant data, Payables for the three prior quarters was $16.1 million (Q1 2026), $24.58 million (Q4 2025) and $15.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn | 22.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.94 Mn |
| Mar 31, 2026 | 16.10 Mn |
| Dec 31, 2025 | 24.58 Mn |
| Sep 30, 2025 | 15.23 Mn |
| Jun 30, 2025 | 50.60 Mn |
| Mar 31, 2025 | 34.16 Mn |
| Dec 31, 2024 | 41.58 Mn |
| Sep 30, 2024 | 57.52 Mn |
| Jun 30, 2024 | 79.96 Mn |
| Mar 31, 2024 | 57.72 Mn |
| Dec 31, 2023 | 132.61 Mn |
| Sep 30, 2023 | 101.91 Mn |
| Jun 30, 2023 | 87.25 Mn |
| Mar 31, 2023 | 124.80 Mn |
| Dec 31, 2022 | 541.40 Mn |
| Sep 30, 2022 | 469.52 Mn |
| Jun 30, 2022 | 710.66 Mn |
| Mar 31, 2022 | 458.94 Mn |
| Dec 31, 2021 | 127.05 Mn |
| Sep 30, 2021 | 59.56 Mn |
API Access
Novavax Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=NVAX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();